ARCHIVES

Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle

This article is from The Cancer Letter archive.

Vol. 20 No. 37 | September 30, 1994

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

August 5, 2011

DCT Issues New Program Announcement On Clinical Research

December 5, 1980